Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02419560
Title Optimal Dose Finding Study ABT-199 and Ibrutinib in MCL
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Craig Portell, MD
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
Winship Cancer Institute, Emory University Atlanta Georgia 30322 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
University of Virginia Charlottesville Virginia 22908 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field